L. M. Appelman

1.2k total citations
18 papers, 873 citations indexed

About

L. M. Appelman is a scholar working on Health, Toxicology and Mutagenesis, Sensory Systems and Cancer Research. According to data from OpenAlex, L. M. Appelman has authored 18 papers receiving a total of 873 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Health, Toxicology and Mutagenesis, 5 papers in Sensory Systems and 5 papers in Cancer Research. Recurrent topics in L. M. Appelman's work include Indoor Air Quality and Microbial Exposure (5 papers), Carcinogens and Genotoxicity Assessment (5 papers) and Olfactory and Sensory Function Studies (5 papers). L. M. Appelman is often cited by papers focused on Indoor Air Quality and Microbial Exposure (5 papers), Carcinogens and Genotoxicity Assessment (5 papers) and Olfactory and Sensory Function Studies (5 papers). L. M. Appelman collaborates with scholars based in Netherlands, Denmark and Switzerland. L. M. Appelman's co-authors include R.A. Woutersen, V.J. Feron, W.F. ten Berge, A. Zwart, Ruud Woutersen, J.W.G.M. Wilmer, C.A. van der Heijden, H.E. Falke, R.N. Hooftman and P.G.J. Reuzel and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Hazardous Materials and Cancer Letters.

In The Last Decade

L. M. Appelman

18 papers receiving 783 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. M. Appelman Netherlands 14 340 275 137 114 83 18 873
Carroll A. Snyder United States 20 390 1.1× 587 2.1× 279 2.0× 43 0.4× 40 0.5× 51 1.2k
F Brugnone Italy 27 710 2.1× 787 2.9× 169 1.2× 37 0.3× 300 3.6× 89 1.7k
Lawrence J. Jenkins United States 14 201 0.6× 270 1.0× 71 0.5× 29 0.3× 31 0.4× 24 651
Hans‐Juergen Haussmann Switzerland 16 361 1.1× 226 0.8× 167 1.2× 32 0.3× 60 0.7× 17 772
Joseph H. Roycroft United States 17 338 1.0× 191 0.7× 164 1.2× 16 0.1× 74 0.9× 34 849
E. Roemer Switzerland 17 638 1.9× 527 1.9× 239 1.7× 31 0.3× 127 1.5× 36 1.4k
Madoka Nakajima Japan 18 336 1.0× 637 2.3× 456 3.3× 34 0.3× 68 0.8× 55 1.3k
Michael W. Ogden United States 19 562 1.7× 106 0.4× 235 1.7× 34 0.3× 141 1.7× 44 1.2k
A. J. Weir United States 23 229 0.7× 135 0.5× 260 1.9× 66 0.6× 57 0.7× 37 1.2k
Kaija Pekari Finland 18 421 1.2× 403 1.5× 85 0.6× 27 0.2× 61 0.7× 29 738

Countries citing papers authored by L. M. Appelman

Since Specialization
Citations

This map shows the geographic impact of L. M. Appelman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. M. Appelman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. M. Appelman more than expected).

Fields of papers citing papers by L. M. Appelman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. M. Appelman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. M. Appelman. The network helps show where L. M. Appelman may publish in the future.

Co-authorship network of co-authors of L. M. Appelman

This figure shows the co-authorship network connecting the top 25 collaborators of L. M. Appelman. A scholar is included among the top collaborators of L. M. Appelman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. M. Appelman. L. M. Appelman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Horst, Geertje van der, Maaike H. van der Mark, L. M. Appelman, et al.. (2020). Cationic amphiphilic drugs as potential anticancer therapy for bladder cancer. Molecular Oncology. 14(12). 3121–3134. 8 indexed citations
2.
Shapiro, Geoffrey I., Jeffrey G. Supko, D. P. Ryan, et al.. (2005). Phase I trial of ARQ 501, an Activated Checkpoint Therapy (ACT) agent, in patients with advanced solid tumors. Journal of Clinical Oncology. 23(16_suppl). 3042–3042. 21 indexed citations
3.
Zwart, A., Josje H.E. Arts, W.F. ten Berge, & L. M. Appelman. (1992). Alternative acute inhalation toxicity testing by determination of the concentration-time-mortality relationship: Experimental comparison with standard LC50 testing. Regulatory Toxicology and Pharmacology. 15(3). 278–290. 17 indexed citations
4.
Wilmer, J.W.G.M., et al.. (1989). Subchronic (13-week) inhalation toxicity study of formaldehyde in male rats: 8-hour intermittent versus 8-hour continuous exposures. Toxicology Letters. 47(3). 287–293. 50 indexed citations
5.
Hooftman, R.N., C. Frieke Kuper, & L. M. Appelman. (1988). Comparative sensitivity of histo‐pathology and specific lung parameters in the detection of lung injury. Journal of Applied Toxicology. 8(1). 59–65. 22 indexed citations
6.
Appelman, L. M., R.A. Woutersen, A. Zwart, H.E. Falke, & V.J. Feron. (1988). One‐year inhalation toxicity study of formaldehyde in male rats with a damaged or undamaged nasal mucosa. Journal of Applied Toxicology. 8(2). 85–90. 35 indexed citations
7.
Feron, V.J., et al.. (1988). Nasal tumours in rats after short-term exposure to a cytotoxic concentration of formaldehyde. Cancer Letters. 39(1). 101–111. 52 indexed citations
8.
Wilmer, J.W.G.M., et al.. (1987). Subacute (4‐week) inhalation toxicity study of formaldehyde in male rats: 8‐hour intermittent versus 8‐hour continuous exposures. Journal of Applied Toxicology. 7(1). 15–16. 26 indexed citations
9.
Woutersen, R.A., L. M. Appelman, J.W.G.M. Wilmer, H.E. Falke, & V.J. Feron. (1987). Subchronic (13‐week) inhalation toxicity study of formaldehyde in rats. Journal of Applied Toxicology. 7(1). 43–49. 56 indexed citations
10.
Appelman, L. M., et al.. (1987). Effects of the exposure profile on the inhalation toxicity of carbon tetrachloride in male rats. Journal of Applied Toxicology. 7(3). 185–191. 5 indexed citations
11.
Woutersen, Ruud, et al.. (1986). Inhalation toxicity of acetaldehyde in rats. III. Carcinogenicity study. Toxicology. 41(2). 213–231. 182 indexed citations
12.
Appelman, L. M. & V.J. Feron. (1986). Significance of the dog as ‘second animal species’ in toxicity testing for establishing the lowest ‘no‐toxic‐effect level’. Journal of Applied Toxicology. 6(4). 271–279. 7 indexed citations
13.
Appelman, L. M., et al.. (1986). Effect of variable versus fixed exposure levels on the toxicity of acetaldehyde in rats. Journal of Applied Toxicology. 6(5). 331–336. 27 indexed citations
14.
Berge, W.F. ten, A. Zwart, & L. M. Appelman. (1986). Concentration—time mortality response relationship of irritant and systemically acting vapours and gases. Journal of Hazardous Materials. 13(3). 301–309. 173 indexed citations
15.
Woutersen, R.A., L. M. Appelman, & C.A. van der Heijden. (1984). Inhalation toxicity of acetaldehyde in rats II. Carcinogenicity study: Interim results after 15 months. Toxicology. 31(2). 123–133. 74 indexed citations
16.
Appelman, L. M., W.F. ten Berge, & P.G.J. Reuzel. (1982). Acute inhalation toxicity study of ammonia in rats with variable exposure periods. American Industrial Hygiene Association Journal. 43(9). 662–665. 31 indexed citations
17.
Appelman, L. M., R.A. Woutersen, & V.J. Feron. (1982). Inhalation toxicity of acetaldehyde in rats. I. Acute and subacute studies. Toxicology. 23(4). 293–307. 81 indexed citations
18.
Appelman, L. M., Coenraad Hendriksen, & V.J. Feron. (1981). Repeated exposure to α-ethylacrolein vapour: Subacute toxicity study in rats. Toxicology. 22(1). 79–87. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026